BRIEF-CSPC Pharmaceutical Group's Shanghai Runshi Enters Agreements With Shanghai Institute Of Materia Medica
Feb 26 (Reuters) - CSPC Pharmaceutical Group Ltd:
* SHANGHAI RUNSHI PHARMA TECHNOLOGY CO ENTERED INTO FOUR AGREEMENTS WITH SHANGHAI INSTITUTE OF MATERIA MEDICA
* SHANGHAI RUNSHI AGREED TO PAY TO SIMM UPFRONT PAYMENTS OF RMB34 MILLION AND DEVELOPMENT MILESTONE PAYMENTS OF UP TO RMB411.7 MILLION
* AGREEMENTS FOR LICENSING OF CO- DEVELOPMENT & COMMERCIALIZATION OF 4 SMALL-MOLECULE COMPOUNDS DEVELOPED BY SIMM Source text for Eikon: Further company coverage: